MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹333 Cr | ₹241 Cr | ₹290 Cr | ₹167 Cr | ₹138 Cr |
What is the latest Total Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹290 Cr |
| Mar2022 | ₹167 Cr |
| Mar2021 | ₹138 Cr |
How is Total Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹333 Cr | 38.03 | |
| Mar2024 | ₹241 Cr | -16.89 | |
| Mar2023 | ₹290 Cr | 74.27 | |
| Mar2022 | ₹167 Cr | 20.76 | |
| Mar2021 | ₹138 Cr | - | |
Compare Total Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹421.2 Cr | 7% | 24.4% | -5.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,480.4 Cr | 3.9% | -4.3% | -14.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,735.7 Cr | 1.5% | 15% | -29.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,148.4 Cr | 4.4% | 21.6% | -8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,072.7 Cr | 5.4% | 21.1% | -14.5% | Stock Analytics | |
| INDO US BIOTECH | ₹219.4 Cr | 2.8% | 10.5% | -31.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | 7% |
24.4% |
-5.8% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses